Cancer News and Research

RSS
Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.
New technique anticipated to deliver personalized immunotherapies for cancer

New technique anticipated to deliver personalized immunotherapies for cancer

Researchers test a neoantigen-specific transgenic immune cell therapy for malignant gliomas

Researchers test a neoantigen-specific transgenic immune cell therapy for malignant gliomas

Advanced tools for Glycobiology research

Advanced tools for Glycobiology research

Green tea catechins extend the lifespan of C. elegans

Green tea catechins extend the lifespan of C. elegans

Cellular enlargement drives a decline in function of stem cells, study suggests

Cellular enlargement drives a decline in function of stem cells, study suggests

Research details how HIV-infected cells evade detection by the immune system

Research details how HIV-infected cells evade detection by the immune system

CRISPR introduces potentially dangerous changes in cells, reveals research

CRISPR introduces potentially dangerous changes in cells, reveals research

Study shows how a common gene mutation robs people of natural cancer protection

Study shows how a common gene mutation robs people of natural cancer protection

Cellular senescence is caused by irreversible damage to the genome

Cellular senescence is caused by irreversible damage to the genome

CRISPR screening identifies metabolic enzyme as new target for anti-inflammatory therapeutics

CRISPR screening identifies metabolic enzyme as new target for anti-inflammatory therapeutics

Using a new genetic technology to decipher intratumoral heterogeneity

Using a new genetic technology to decipher intratumoral heterogeneity

Scientists discover new genetic link to non-alcoholic inflammatory liver disease

Scientists discover new genetic link to non-alcoholic inflammatory liver disease

Targeting Shp2 as a cancer therapy may worsen the disease

Targeting Shp2 as a cancer therapy may worsen the disease

New model for early prediction of cancer patients' response to immunotherapy

New model for early prediction of cancer patients' response to immunotherapy

Cancer invasion and migration can be suppressed by manipulating stiffness of cell membrane

Cancer invasion and migration can be suppressed by manipulating stiffness of cell membrane

Study discusses outcomes of disclosing actionable genetic results to research participants

Study discusses outcomes of disclosing actionable genetic results to research participants

Whole genome sequencing for children with cancer provides accurate diagnosis

Whole genome sequencing for children with cancer provides accurate diagnosis

Biognosys Launches Next-Generation Blood Biomarker Discovery Solution

Biognosys Launches Next-Generation Blood Biomarker Discovery Solution

Transformative technology aims to provide insights into the function of immune cells

Transformative technology aims to provide insights into the function of immune cells

Torquetenovirus in people infected by SARS-CoV-2 can be used as a marker of disease severity

Torquetenovirus in people infected by SARS-CoV-2 can be used as a marker of disease severity

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.